1. Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy (Review)
    Hani Choudhry et al, 2017, Oncology Letters CrossRef
  2. YTHDF1 promotes gallbladder cancer progression via post‐transcriptional regulation of the m6A/UHRF1 axis
    Jiemin Chen et al, 2024, Journal of Cellular and Molecular Medicine CrossRef
  3. ZBTB7A promotes migration, invasion and metastasis of human breast cancer cells through NF-κB-induced epithelial–mesenchymal transition in vitro and in vivo
    Anyun Mao et al, 2019, The Journal of Biochemistry CrossRef
  4. Pancreatic cancer stem cell markers and exosomes - the incentive push
    Sarah Heiler et al, 2016, World Journal of Gastroenterology CrossRef
  5. UHRF1 Knockdown Attenuates Cell Growth, Migration, and Invasion in Cutaneous Squamous Cell Carcinoma
    Qingyan Li et al, 2021, Cancer Investigation CrossRef
  6. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma
    Xincheng Liu et al, 2017, Oncotarget CrossRef
  7. Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
    Crescenzo D’Alterio et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
  8. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition
    Jiawen Xu et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  9. Central Role of C2H2-Type Zinc Finger-Containing Genes in Pediatric Brain Tumors
    Dimitrios S. Kanakoglou et al, 2022, DNA CrossRef
  10. Comprehensive analysis of ubiquitin-proteasome system genes related to prognosis and immunosuppression in head and neck squamous cell carcinoma
    Juncheng Wang et al, 2021, Aging CrossRef
  11. Enhanced CXCR4 Expression Associates with Increased Gene Body 5-Hydroxymethylcytosine Modification but not Decreased Promoter Methylation in Colorectal Cancer
    Alexei J. Stuckel et al, 2020, Cancers CrossRef
  12. Bone marrow overexpression of SNAI1 is an early indicator of intrinsic drug resistance in patients with de novo acute myeloid leukemia
    Mahmoud B. Y. Gouda et al, 2023, The Journal of Gene Medicine CrossRef
  13. Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma
    Tomohiro Iguchi et al, 2018, Oncology CrossRef
  14. Downregulation of UHRF1 increases tumor malignancy by activating the CXCR4/AKT-JNK/IL-6/Snail signaling axis in hepatocellular carcinoma cells
    Ji-Hyun Kim et al, 2017, Scientific Reports CrossRef
  15. New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
    Crescenzo D’Alterio et al, 2020, Cancers CrossRef
  16. The role of ubiquitination and deubiquitination in the regulation of cell junctions
    Junting Cai et al, 2018, Protein & Cell CrossRef